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Abstract
Background: Chronic exposure to the glucocorticoid hormone corticosterone exerts cellular stress-induced toxic effects 
that have been associated with neurodegenerative and psychiatric disorders. Docosahexaenoic acid is a polyunsaturated 
fatty acid that has been shown to be of benefit in stress-related disorders, putatively through protective action in neurons.
Methods: We investigated the protective effect of docosahexaenoic acid against glucocorticoid hormone corticosterone-
induced cellular changes in cortical cell cultures containing both astrocytes and neurons.
Results: We found that glucocorticoid hormone corticosterone (100, 150, 200 μM) at different time points (48 and 72 hours) 
induced a dose- and time-dependent reduction in cellular viability as assessed by methyl thiazolyl tetrazolium. Moreover, 
glucocorticoid hormone corticosterone (200 μM, 72 hours) decreased the percentage composition of neurons while increasing 
the percentage of astrocytes as assessed by βIII-tubulin and glial fibrillary acidic protein immunostaining, respectively. In 
contrast, docosahexaenoic acid treatment (6 μM) increased docosahexaenoic acid content and attenuated glucocorticoid 
hormone corticosterone (200  μM)-induced cell death (72 hours) in cortical cultures. This translates into a capacity for 
docosahexaenoic acid to prevent neuronal death as well as astrocyte overgrowth following chronic exposure to glucocorticoid 
hormone corticosterone. Furthermore, docosahexaenoic acid (6 μM) reversed glucocorticoid hormone corticosterone-induced 
neuronal apoptosis as assessed by terminal deoxynucleotidyl transferase–mediated nick-end labeling and attenuated 
glucocorticoid hormone corticosterone-induced reductions in brain derived neurotrophic factor mRNA expression in 
these cultures. Finally, docosahexaenoic acid inhibited glucocorticoid hormone corticosterone-induced downregulation of 
glucocorticoid receptor expression on βIII- tubulin-positive neurons.
Conclusions: This work supports the view that docosahexaenoic acid may be beneficial in ameliorating stress-related cellular 
changes in the brain and may be of value in psychiatric disorders.
Keywords: Docosahexaenoic acid, corticosterone, stress, glucocorticoid receptors, brain derived neurotrophic factor
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Introduction
Many neuropsychiatric disorders, including anxiety and 
depression, are associated with alterations in the hypotha-
lamic-pituitary-adrenal axis and elevated concentrations of 
glucocorticoids (Kronenberg et  al., 2009). Preclinical studies 
have shown that chronic exposure to glucocorticoids is dele-
terious to the structural and functional plasticity of adult rat 
brain (Sapolsky and Pulsinelli, 1985; Zhu et al., 2013), although 
acute treatment with glucocorticoids can be neuroprotective 
(Jeanneteau et al., 2008). Chronic elevation of glucocorticoid lev-
els alters the cellular composition and white matter structure 
of rodent hippocampus both in vitro and in vivo (Chetty et al., 
2014) and induces a number of behavioral abnormalities simi-
lar to depression and anxiety in mice (Ardayfio and Kim, 2006; 
Murray et al., 2008).
Stress-induced increases in glucocorticoids has also been 
shown to impair the prefrontal cortex (PFC) structure and func-
tion (Arnsten, 2009). Indeed, the PFC is one of the most sensi-
tive brain areas to the detrimental effects of stress exposure 
(Arnsten, 2009) and has a high density of glucocorticoid recep-
tors (GRs) (Chao et al., 1989; Barsegyan et al., 2010). High doses 
of glucocorticoids have been shown to impair PFC-dependent 
working memory in humans (Lupien et  al., 1999). Moreover, 
chronic corticosterone (CORT) treatment has also been shown to 
produce neuronal impairment in the PFC, such as reduced distal 
dendritic spines of neurons and neuronal loss in rats (Wellman, 
2001; Seib and Wellman, 2003; Cerqueira et al., 2005). An inverse 
relationship between glucocorticoid levels and brain derived 
neurotrophic factor (BDNF), a neurotrophin involved in cellular 
plasticity and neuronal survival (Lipsky and Marini, 2007), has 
been described both in humans and rodents (Issa et al., 2010). 
Strategies to attenuate the effects of glucocorticoids on brain 
function may result in novel treatment approaches for depres-
sion and anxiety.
Docosahexaenoic acid (DHA; 22:6n-3) represents the most 
abundant omega-3 polyunsaturated fatty acid (PUFA) in the 
mammalian brain, and as such it has been implicated in the 
regulation of brain structure, signalling, and plasticity (Salem 
et al., 2001; Sharma et al., 2012; Crupi et al., 2013). DHA, mostly 
concentrated in the frontal cortex and hippocampus of rat (Xiao 
et al., 2005), regulates frontal cortex BDNF levels both in vitro 
and in vivo (Rao et al., 2007). Moreover, it has been shown that 
BDNF/DHA cotreatment reduced cell death by approximately 
50% compared with controls in vitro after chronic treatment 
of either 72 or 144 hours (Calandria et al., 2012). In accordance 
with these findings, chronic PUFA supplementation promotes 
beneficial effects on anxiety and depressive-like behaviors in 
stress-induced animals (Ferraz et  al., 2011). Moreover, grow-
ing evidence points to a decreased dietary PUFA intake associ-
ated with an increased prevalence of mental illness, including 
stress-related diseases (McNamara et  al., 2007; Levant et  al., 
2008; Mathieu et  al., 2011). Indeed, postmortem orbitofrontal 
cortex DHA levels are 22% lower in major depressive disorder 
patients relative to normal controls (McNamara et  al., 2007). 
Clinical observations have shown chronic PUFA supplementa-
tion to be beneficial in reducing certain anxiety behaviors as 
well as in treating major depressive disorder (Yehuda et  al., 
2005; Grosso et al., 2014).
In view of the above, we investigated whether DHA could 
abrogate CORT-induced toxic effects in primary cortical cell cul-
tures that contained both astrocytes and neurons. Furthermore, 
we predicted that these effects would be related to molecular 
changes at the level of BDNF and GR.
Materials and Methods
Primary Cultures of Postnatal Day 1/2 Rat Cortex
All scientific procedures were carried out in line with Directive 
2010/63/EU and were approved by the Animal Experimentation 
Ethics Committee of University College Cork #2012/036. Mixed 
cortical cell cultures, consisting of both neurons and astro-
cytes, were prepared from postnatal day 1/2 Sprague Dawley 
rats (Biological Services Unit, University College Cork) as pre-
viously described (Long-Smith et  al., 2010). Rats were decapi-
tated, the cerebral cortices dissected out, and the meninges 
removed. Tissue was mechanically dissociated and incubated 
in trypsin (0.25 μg/mL, Sigma-Aldrich) for 15 minutes at 37°C 
with 5% CO2. This was replaced with prewarmed dissociation 
medium (DMEM-F12 supplemented with fetal calf serum [10%, 
Sigma-Aldrich] and DNase [0.1 mg/mL, Sigma-Aldrich]). The 
suspension was inverted gently for 1 minute, triturated with 
a flame-polished Pasteur pipette, and passed through a sterile 
mesh filter (40 μm). The suspension was centrifuged at 200g for 
5 minutes at 20°C, and the pellet was resuspended in warm cul-
ture media (DMEM-F12 supplemented with fetal calf serum [1%, 
Sigma-Aldrich], B-27 [2%, Gibco], penicillin/streptomycin [1%], 
d-glutamine [1%, Sigma-Aldrich], and d-glucose [55 mM, Sigma-
Aldrich]). Suspended cells were plated at a density of 4.5 × 104 
cells on circular 13-mm-diameter coverslips, coated with poly-
D-lysine (0.1 mg/mL, Sigma-Aldrich) in a 24-well plate, and incu-
bated in a humidified atmosphere containing 5% CO2: 95% O2 at 
37°C for 2 hours prior to being flooded with prewarmed culture 
media. The day after, all cells were grown in culture medium 
containing α-tocopherol (40 μM), bovine serum albumin (0.01%), 
and ethanol (0.3%). Thereafter, one-half of the media was 
replaced every 2 to 3 days for the duration of the experiment.
Treatment
Dose Response of Effect of CORT on Mixed Cortical Cultures
First, we assessed the optimal dose of CORT in mixed corti-
cal cultures. The experimental timeline is shown in Figure 1D. 
Briefly, cells were treated with CORT (75, 100, 150, 200 μM) after 
7, 8, or 9 divisions (DIV), respectively.
RU486 and Spironolactone Effects on Mixed Cortical Cultures
Second, we determined whether GRs or mineralcorticoid recep-
tors (MRs) mediated the effect of CORT in mixed cortical cul-
tures. The experimental timeline is shown in Figure 1D. Briefly, 
cells were cotreated with CORT (200 μM) and with the GR antag-
onist RU486 (10 μM) or the MR antagonist spironolactone (SPIRO; 
50 μM) after 7 DIV.
Dose Response of Effect of DHA on Mixed Cortical Cultures
Third, we assessed the optimal dose of DHA in mixed corti-
cal cultures. The experimental timeline is shown in Figure 2B. 
Briefly, cells were treated with DHA (3, 6 μM) after 1 DIV.
Preventive Effect of DHA against CORT on Mixed Cortical 
Cultures
Fourth, we determined whether DHA reversed CORT-induced 
effect on mixed primary culture. The experimental timeline 
is shown in Figure  2B. Briefly, cells were pretreated with DHA 
(6 μM) after 1 DIV before treatment with CORT (200 μM) after 
7 DIV.
To avoid DHA oxidation, one-half of the media was replaced 
every 2 to 3 days. DHA, CORT, RU486, SPIRO, α-tocopherol, and 
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bovine serum albumin-fatty acids free were purchased from 
Sigma-Aldrich. All treatments were freshly prepared.
Methyl Thiazolyl Tetrazolium (MTT) Assay
Cell viability was assessed by measuring the reduction of 
MTT by mitochondrial dehydrogenase of viable cells as previ-
ously described (Godinho et  al., 2014). Medium was removed 
and replaced with 300 μL of fresh culture medium containing 
MTT reagent (1 mg/mL) for 3 hours at 37oC. The formazan crys-
tals produced were dissolved in 100 μL of dimethyl sulfoxide. 
Absorbance was measured at 590 nm using a UV plate reader. 
Four wells per treatment were analyzed from 3 independent 
experiments. Results were expressed as percent dehydrogenase 
activity compared with untreated controls.
Fatty Acid Analysis
For fatty acid analysis, cells were washed in Hank’s Balanced 
Salt Solution. Trypsin (0.25 μg/mL, Sigma-Aldrich) was used to 
remove adherent cells from culture surface and harvested with 
a cell scraper. Cells were then spun down at 1200 rpm for 5 min-
utes and supernatant was discarded. Lipids were extracted from 
cell pellets with chloroform:methanol (2:1 v/v) as described 
previously (Folch et al., 1957). Fatty acid methyl esters (FAMEs) 
were prepared by first using 10 mL 0.5 N NaOH in methanol for 
10 minutes at 90°C followed by 10 mL 14% BF3 in methanol for 
10 minutes at 90°C (Park and Goins, 1994). FAMEs were recovered 
with hexane. Prior to gas chromatography analysis, samples 
were dried over anhydrous sodium sulphate (0.5 g) for 1 hour, 
concentrated under nitrogen, and stored at -20°C. FAMEs were 
separated using gas chromatography (Agilent 7890B, Agilent 
Technologies, Santa Clara, CA) fitted with a flame ionisation 
detector, using a Chrompack CP Sil 88 column (Chrompack, 
JVA Analytical, 100-m × 0.25-mm internal diameter, 0.25-μm 
film thickness) and helium as the carrier gas. The column oven 
was programmed to be held initially at 80°C for 8 minutes and 
increased to 8.5°C/min to a final column temperature of 200°C. 
The injection volume used was 0.5 μL, with an automatic sample 
injection (CTC Autosampler, Model 80) on an Aglient Multimode 
Inlet on-column temperature programmable injector. Peaks 
were integrated using the Agilent OpenLAB Chemstation soft-
ware (version A.01.06.111). Identification of FAMEs was carried 
out by comparison of retention times with pure FAME standards 
(Nu-Chek Prep, Elysian, MN) and quantified against an internal 
standard (C17:0). Results are expressed as g/100 g total FAME.
Immunocytochemistry
Culture media was removed and cells were washed with pre-
warmed Hank’s Balanced Salt Solution. Cells were fixed with 
ice-cold methanol for 10 minutes at -20°C and subsequently 
washed and permeabilized in phosphate buffered solution (PBS) 
containing Tween 20 (0.02%) 3 times for 5 minutes. Cells were 
incubated in 5% normal horse serum in PBS containing Tween 20 
overnight at 4 °C to attenuate nonspecific antibody binding. Cells 
were incubated overnight at 4°C in antibodies that target βIII-
tubulin-positive neurons (1:300; mouse monoclonal, Promega), 
glial fibrillary acidic protein (GFAP)-positive astrocytes (1:300; 
rabbit polyclonal, Dako), or GRs (1:100; rabbit monoclonal, Cell 
Signaling). Cells were subsequently incubated in the appropri-
ate secondary antibody: Alexa Fluor 488 donkey anti-rabbit IgG 
or Alexa Fluor 594 donkey anti-mouse IgG (all 1:2000; Molecular 
Probes). Cells were counterstained with bisbenzimide (1:2500; 
Sigma-Aldrich) to identify the nuclei and mounted onto glass 
coverslips with an aqueous mounting medium (Dako). For each 
antibody, the cells from one coverslip were incubated in block-
ing solution and secondary antibody, without primary antibody 
Figure 1. Corticosterone (CORT)-induced reduction in dehydrogenase activity in rat mixed cortical cultures is prevented by glucocorticoid receptor (GR) antagonist 
RU486. (A-C) CORT dose-dependent reduction in dehydrogenase activity at 24, 48, and 72 hours, respectively. (D) Schematic representing CORT, GR antagonist RU486, 
and mineralcorticoid receptor (MR) antagonist spironolactone (SPIRO) treatments. (E) RU486 (10 μM), but not SPIRO (50 μM), blocks the decrease in dehydrogenase activ-
ity upon treatment with CORT. Intergroup comparisons: *P < 0.05, **P < 0.01, and ***P < 0.001 compared with control (-); &&P < 0.01 compared with CORT (200 μM). Data 
are presented as mean ± SEM (n = 3).
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(to account for nonspecific binding of the secondary antibody), 
and showed a complete absence of immunofluorescent staining 
(data not shown).
Cell Counts and Densitometry
An upright microscope (AX70, Olympus, Hamburg, Germany) 
was used to analyze the immuno-positive cell composition of 
the primary culture as previously described (Green and Nolan, 
2012). Immuno-positive cells were counted in 5 randomly cho-
sen fields of view from each of the 4 coverslips and divided by 
the total number of cells per 5 fields of view to give an aver-
age percentage for each coverslip. Only βIII-tubulin or GFAP-
positive cells with a differentiated phenotype were counted. 
Four wells per treatment were analyzed from 3 independent 
experiments. The densitometry of 40 GR-positive neurons, 
selected from 5 randomly chosen fields of view from each of 
the 3 coverslips per treatment, was carried out using Image J 
software (version 1.38X, NIH, Bethesda, MD). For each photo-
micrograph, background measurements were subtracted from 
each GR-positive cell value to obtain a corrected fluorescence 
measurement. Each experiment was independently repeated 
3 times.
TUNEL: Apoptosis
Fragmented DNA of apoptotic cells was measured using the ter-
minal deoxynucleotidyl transferase–mediated nick-end labeling 
(TUNEL) staining provided by the DeadEnd Fluorometric TUNEL 
System according to the manufacturer’s instructions (Promega). 
Cells were counterstained with bisbenzimide (1:2500; Sigma-
Aldrich) to label nuclei and double stained with ΒIII-tubulin 
(1:300; mouse monoclonal, Promega) to detect apoptotic neu-
rons. Apoptotic-positive cells and apoptotic-positive neurons 
were counted in 5 randomly chosen fields of view from each of 
the 4 coverslips and divided by the total number of cells or the 
total number of neurons, respectively, per 5 fields of view to give 
an average percentage for each coverslip. Four wells per treat-
ment were analyzed from 3 independent experiments.
RNA Isolation and Quantitative Real-Time PCR
Total RNA was isolated from mixed cortical primary culture 
using the ReliaPrep RNA Cell Miniprep system as per the manu-
facturer’s instructions (Promega). Briefly, cells were harvested 
using a denaturing lysis solution. The lysate was then trans-
ferred to a microcentrifuge tube in the presence of isopropanol 
and centrifuged. The filter was then washed and finally the RNA 
was eluted using Nuclease-Free Water. Isolated RNA was stored 
at -80°C until further processing. RNA concentration was quan-
tified using the ND-1000 spectrophotometer (NanoDrop), and 
RNA quality was assessed using the Agilent 2100 Bioanalyzer.
Analysis of RNA expression levels was carried as previously 
described (O’ Connor et al., 2013). Briefly, equal amounts of RNA 
were first reverse transcribed to cDNA using High Capacity 
cDNA Reverse Transcription Kit (Applied Biosystems, Life 
Technologies, Carlsbad, CA). Real-time PCR was performed using 
TaqMan Universal Master Mix II, no UNG, and TaqMan Gene 
Expression Assays designed by Applied Biosystems for rat genes 
on the ABI7300 Real Time PCR machine (Applied Biosystems, 
Warrington, UK). Each sample was analyzed in triplicate for 
both target gene and endogenous control using the 7300 System 
SDS Software (Applied Biosystems, Life Technologies). All assays 
were controlled for the absence of genomic DNA amplification. 
β-actin (VIC/MGB Probe, Primer Limited, Applied Biosystems) 
was used as an endogenous control. Cycle threshold (Ct) values 
were recorded. The Ct value for the target gene in each sample 
was normalized to its endogenous control transformed to rela-
tive gene expression value using the 2−ΔCt method (Simen et al., 
2006). Four wells per treatment were analyzed from 3 independ-
ent experiments.
BDNF Protein Detection Levels by ELISA
Supernatant was collected from cortical cell cultures. Cortical 
cells where lysed using T-PER buffer (Thermo scientific) contain-
ing protease and phosphatase inhibitor cocktail (Roche). Cell 
extracts were obtained after centrifugation at 14 000g for 10 min-
utes. Protein concentrations from each sample were then meas-
ured using a Pierce BCA protein assay kit (Thermo scientific) 
and normalized. Thus, BDNF levels were measured in cellular 
media and cortical cellular extracts using an ELISA kit according 
to the manufacturer’s instructions (BDNF Emax Immunoassay 
(Promega Corp, Madison, WI). Briefly, the monoclonal antibody 
was added to each well of a 96-well plate and incubated over-
night at 4°C. The following were added to the wells sequentially: 
samples and BDNF standards in duplicate (incubated 2 hours at 
room temperature), anti-human BDNF pAb (incubated 2 hours 
Figure 2. Docosahexaenoic acid (DHA) prevented corticosterone (CORT)-induced 
reduction in dehydrogenase activity in rat mixed cortical cultures. (A) DHA dose-
dependent increase in dehydrogenase activity. (B) Schematic representing CORT 
and DHA treatments. (C) DHA prevention of CORT-induced reduction in dehy-
drogenase activity. Intergroup comparisons: **P < 0.01 and ***P < 0.001 compared 
with control (-); &P < 0.05 compared with CORT (200 μM). Data are presented as 
mean ± SEM (n = 3).
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at room temperature), anti-IgY HRP (incubated 1 hour at room 
temperature), and TMB solution (incubated 20 minutes at room 
temperature). The plate was washed with Tris-buffered saline 
0.05% Tween 20 buffer. Finally, a stop solution was added, and 
absorbance was read at 450 nm using a microplate reader (Bio-
Rad Laboratories) within 30 minutes of the addition of the stop 
solution. BDNF concentration was calculated based on a stand-
ard curve. Values are expressed in pg/mL protein.
Statistics
All data are presented as mean ± SEM. Data were analyzed using 
a 1 or 2-way ANOVA as appropriate, followed by Fisher’s LSD 
posthoc test, using the statistical software package SPSS 21.0 
(IBM). A P-value of 0.05 was selected as the threshold of statisti-
cal significance.
Results
MTT: Cell Viability
We first analyzed the effect of a range of CORT concentration (75, 
100, 150, 200 μM) on dehydrogenase activity in rat mixed cortical 
cultures at different time points (24, 48, 72 hours) using the MTT 
assay (Figure 1A-C). Administration of CORT for a period of 24 
hours did not induce changes in dehydrogenase activity at any of 
the concentrations used (Figure 1A). However, after both 48 and 
72 hours, CORT treatment (200 μM) significantly reduced dehy-
drogenase activity (P < .05; P < .001) while also reducing its activity 
after treatment with 150 μM for 72 hours (P < .01) (Figure 1B-C). To 
determine if GRs or MRs mediated the effect, we cotreated cells 
with CORT (200 μM) and with the GR antagonist RU486 (10 μM), 
or the MR antagonist SPIRO (50  μM) for 72 hours. RU486, but 
not SPIRO, significantly attenuated the CORT-induced decrease 
in dehydrogenase activity (P < .01), indicating that this effect is 
mediated by the GR (Figure 1E). Secondly, we analyzed the effect 
of DHA on dehydrogenase activity and its potential protective 
effect against CORT (200 μM, 72 hours). DHA (6 μM) induced an 
increase in dehydrogenase activity compared with untreated 
control cultures (P < .01) (Figure 2A). Moreover, this concentration 
of DHA reversed CORT-induced decrease in dehydrogenase activ-
ity in rat mixed cortical cultures (P < .05) as shown in Figure 2C.
Fatty Acids Analysis
Subsequently, we wished to establish the effects of both CORT 
(200 μM) and DHA (6 μM) on the fatty acid cellular composition of 
rat mixed cortical cultures. Administration of DHA significantly 
increased DHA content in both DHA and CORT+DHA groups. In 
contrast, CORT (200 μM, 72 hours) increased the n-6:n-3 fatty 
acids ratio compared with all the groups (Table 1).
Immunostaining: Quantification of Cell Phenotypes
To examine the effects of both CORT and DHA on the cel-
lular composition of rat mixed cortical cultures, cells were 
treated with CORT (200 μM, 72 hours) or DHA (6 μM, 9 DIV) or 
pretreated with DHA for 6  days before treatment with CORT, 
as described above. Immunocytochemistry for bisbenzimide, 
βIII-tubulin, and GFAP was used to visualize cellular nuclei, 
postmitotic neurons, and astrocytes, respectively (Figure  3A). 
CORT decreased the number of total cells (P < .05) as shown in 
Figure  3B. Moreover, CORT exerted a bimodal effect on cellu-
lar composition. Specifically, CORT decreased the percentage 
composition of neurons (P < .001) while increasing the percent-
age of astrocytes in culture (P < .01) (Figure 3C-D). DHA attenu-
ated the CORT-dependent decrease in number of total cells 
stained with bisbenzimide. Furthermore, DHA reversed both the 
CORT-induced decrease in the percentage composition of neu-
rons (P < .01) and the increase in the percentage composition of 
astrocytes (P < .05) in these cultures (Figure 3C-D).
TUNEL: Apoptosis
To establish whether the CORT-induced reduction of the 
mitochondrial dehydrogenase activity is due to apoptosis, 
we analyzed the percentage of total apoptotic cells as well as 
of apoptotic neurons in mixed cortical cultures (Figure  4A). 
Furthermore, we investigated a potential reversal effect exerted 
by DHA. CORT treatment (200 μM, 72 hours) induced a trend 
toward an increased percentage of apoptotic cells (P = .079) as 
well as significantly increasing the percentage composition of 
apoptotic neurons (P < .01). In contrast, pretreatment with DHA 
(6 μM, 6 DIV) reversed the CORT-induced increase in total apop-
totic cells (P < .01) and apoptotic neurons (P < .01) (Figure 4B-C).
GR Expression
Having established that DHA ameliorated CORT-related cellular 
changes in rat mixed cortical cultures, we wanted to establish the 
molecular mechanisms implicated in these effects. We focused 
specifically on the GR, as treatment with the GR antagonist RU486 
prevented CORT-induced cell death. Immunocytochemical anal-
yses revealed that CORT decreased the expression levels of GR in 
mature neurons (P < .01). Interestingly, pretreatment with DHA 
inhibited the CORT-induced downregulation of GR expression 
on βIII-tubulin-positive neurons (Figure 5A-B).
Table 1. Fatty Acids Analysis
Control DHA (6 μM) CORT (200 μM) CORT+DHA
SFA
14:0 3.1 ± 0.2 2.9 ± 0.4 3.1 ± 0.2 3.2 ± 0.4
16:0 39.5 ± 1.1 41.5 ± 1 39.6 ± 1.1 39.5 ± 0.9
18:0 25.5 ± 0.4 25 ± 0.9 27.3 ± 0.3* 26.0 ± 0.8
20:0 0.7 ± 0 0.5 ± 0.2 0.8 ± 0.1 0.8 ± 0.1
Total SFA 68.8 69.9 70.8 69.4
MUFA
16:1 1.1 ± 0.1 1.4 ± 0.3 1.1 ± 0.1 1.0 ± 0
18:1t n-9 3.0 ± 0.3 1.9 ± 0.7* 3.2 ± 0.3 3.1 ± 0.3
18:1c n-9 14.8 ± 0.5 14.7 ± 0.9 12.6 ± 0.2** 13.8 ± 0.8
18:1 t n-7 1.7 ± 0.1 1.6 ± 0.1 1.4 ± 0.1 1.5 ± 0.2
Total MUFA 20.6 19.7 18.4 19.4
PUFA
18:2 n-6 2.5 ± 0.1 2.7 ± 0.3 2.8 ± 0.1 2.5 ± 0.3
18:3 n-6 4.0 ± 0.5 3.3 ± 1.0 4.7 ± 0.5 4.6 ± 0.5
20:4 n-6 2.8 ± 0.3 2.5 ± 0.5 2.8 ± 0.5 2.5 ± 0.3
22:4 n-6 0.3 ± 0.3 n.d. 0.1 ± 0.1 n.d.
22:6 n-3 1.0 ± 0.3 1.9 ± 0.6* 0.5 ± 0.4 1.6 ± 0.2&
Total PUFA 10.6 10.4 10.8 11.2
n6:n3 10.1 4.4 22.5 5.9
Abbreviations: CORT, corticosterone; DHA, docosahexaenoic acid; MUFA, mono-
unsaturated fatty acid; n.d., not detected; PUFA, polyunsaturated fatty acid; 
SFA, saturated fatty acid.
*P < .05 relative to control, **P < .01 relative to control, &P < .05 relative to CORT 
(200 μM). Data are expressed as mean g/100g total FAME ± SEM of duplicate 
samples from 3 independent experiments.
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Figure 3. Docosahexaenoic acid (DHA) prevented corticosterone (CORT)-induced changes in the cellular composition of rat mixed cortical cultures. (A) Representative 
photomicrographs of cells immunocytochemically stained for βIII-tubulin (green), glial fibrillary acidic protein (GFAP) (red), and bisbenzimide (blue). (B) Quantifica-
tion of total cells stained with bisbenzimide. (C) Percentage composition of βIII-tubulin+cells (D) and GFAP+cells. Scale bar = 50 μm. Intergroup comparisons: *P < 0.05, 
**P < 0.01 compared with control; &P < 0.05 and &&&P < 0.01 compared with CORT (200 μM). Data are presented as mean ± SEM (n = 3).
Figure 4. Docosahexaenoic acid (DHA) prevented corticosterone (CORT)-induced apoptosis in rat mixed cortical cultures. (A) Representative photomicrographs of cells 
immunocytochemically stained for terminal deoxynucleotidyl transferase–mediated nick-end labeling (TUNEL) (red), βIII-tubulin (green), and bisbenzimide (blue). (B) 
Percentage composition of TUNEL+cells. (C) Percentage of βIII-tub+TUNEL+/ βIII-tub+cells. Scale bar = 100 μm. Intergroup comparisons: **P < 0.01 compared with control; 
&P < 0.05 and &&P < 0.01 compared with CORT (200 μM). Data are presented as mean ± SEM (n = 3).
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BDNF mRNA and Protein Expression Levels
Subsequently, we wished to establish whether CORT-induced 
GR downregulation in neurons is associated with reductions in 
the neurotrophin BDNF mRNA levels and whether such effects 
are reversed by DHA intervention. In CORT-treated (200 μM, 72 
hours) rat mixed cortical cultures, we found a significant reduc-
tion in BDNF (P < .05) expression levels. DHA reversed the CORT-
induced decrease in BDNF mRNA expression levels, as shown 
in Figure 5C. However, no changes were observed at BDNF pro-
tein levels in any of the experimental groups upon treatment 
(Figure 5D-E).
Discussion
The present study demonstrates a key role for DHA in reversing 
CORT-induced cellular changes in cerebral cortex. Specifically, 
we show that CORT-induced cellular toxicity exerts a bimodal 
effect on the neuronal and glial cell composition, which is abol-
ished by DHA treatment in vitro. We demonstrate that DHA 
reverses CORT-induced neuronal apoptosis and attenuates 
CORT-induced reductions in BDNF expression levels in these 
cultures. We show that DHA inhibits CORT-induced downregu-
lation of GR expression on neurons.
We first demonstrated that CORT, in a dose- and time-
dependent manner, reduces rat cortical cell viability. In accord-
ance with our findings, a CORT-dependent decreased cellular 
viability in different rat brain areas such as cortex (Liu et  al., 
2010a, 2010b), hippocampus (Zhou et al., 2000), and hypothala-
mus (Zhang et al., 2012) has been already shown. We also dem-
onstrated that CORT treatment increased the n-6:n-3 fatty acid 
ratio. A  higher n-6:n-3 ratio has been previously associated 
with the development of stress-related pathologies (Maes et al., 
1996; Peet et al., 1998). Interestingly, our study showed differen-
tial CORT effects on the cellular composition of the rat mixed 
cortical primary culture. Indeed, the percentage composition of 
neuronal cells was reduced by CORT, whereas the percentage 
of astrocytes was increased. Specifically, our data also showed 
that cortical neuronal cell death was induced by apoptosis. That 
CORT decreases the number of neurons is in line with earlier 
in vitro and in vivo investigations at cortical, hippocampal, and 
hypothalamic levels (Sapolsky et  al., 1985; Crochemore et  al., 
2005; Liu et  al., 2010a, 2010b; Zhu et  al., 2013). However, evi-
dence of the impact of glucocorticoids on glial cells is limited. 
Bridges et  al. (2008) have shown that chronic CORT adminis-
tration, over a period of 21 days, increases astrocyte numbers 
in the CA1 hippocampal region of both male and female rats. 
Accordingly, it has been shown that stress increases the hip-
pocampal GFAP-immunoreactive astrocytes by 30% compared 
with control (Lambert et  al., 2000). However, the meaning of 
astrocyte overgrowth subsequent to stress or CORT treatment 
remains unknown. This phenomenon could be considered as 
part of a greater neuronal damage by impeding the neuron-glia 
interaction. Indeed, astrogliosis has been shown to impede the 
Figure 5. Docosahexaenoic acid (DHA) prevented corticosterone (CORT)-induced changes in the glucocorticoid receptor (GR) and in the gene expressions of rat mixed 
cortical cultures. (A) Representative photomicrographs of cells immunocytochemically stained for βIII-tubulin (green) and GR (red). (B) Mean densitometry analysis of 
GR protein in βIII-tubulin+cells. Scale bar = 100 μm. (C) Relative brain derived neurotrophic factor (BDNF) gene expression from RNA extracted by rat mixed cortical cul-
tures. (D- E) BDNF protein expression levels in rat mixed cortical cultures. Intergroup comparisons: **P < 0.01 compared with control, &&P < 0.01 compared with CORT 
(200 μM). Data are presented as mean ± SEM (n = 3).
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movement of substances through the extracellular space, alter-
ing the extra-synaptic communication between glia and glia, 
and glia and neurons (Sykova, 2001, 2004, 2005; Sykova et  al., 
2002). This may also provide further understanding in regards 
to impairments in cognition and emotional state observed as a 
consequence of chronic stress (Lupien et al., 2009). Noteworthy, 
alteration in neuronal and glial cell loss, cell atrophy, or 
increased number of cells have been reported postmortem in 
psychiatric disorders (Rajkowska, 2000).
DHA treatment had a significant impact on cortical cell cul-
tures treated with CORT. Indeed, we found that a specific DHA 
dose (6 μM) increased DHA cellular content as well as prevented 
CORT cellular death and neuronal apoptosis. These data are in 
agreement with other studies that showed increased neuronal 
survival as well as prevention of cortical neuronal apoptosis in 
primary culture after DHA treatment (Cao et al., 2005; Florent 
et  al., 2006). Accordingly, increased DHA content in the brain 
has been found to protect against several neurotoxic insults 
such as ischemia (Belayev et al., 2009), glutamate excitotoxicity 
(Blondeau et al., 2002; Ozyurt et al., 2007), and traumatic head 
injury (Wu et  al., 2004). Of note, although DHA increased the 
percentage of dehydrogenase activity, it did not significantly 
reverse CORT-induced cell loss observed by counting the total 
number of cellular nuclei in these cultures. The reason of this 
discrepancy may be due to the two different methods applied. 
The analysis of dehydrogenase activity assesses cellular meta-
bolic activity, which reflects the number of viable cells present 
in the cultures. Instead, the manual counting of cellular nuclei 
represents a direct method of analysis of cell viability. Moreover, 
the ability of DHA to reverse CORT-induced increase percentage 
composition of astrocytes may be the reason why DHA did not 
significantly reverse CORT-induced cell loss.
Both GR and MR represent the receptors through which CORT 
exerts its effects. The fact that blockade of CORT-induced cellu-
lar changes by cotreatment of the cell culture with RU486, a GR 
antagonist, but not with SPIRO, an MR antagonist, suggests that 
CORT exerts its effect on cell viability through the activation 
of the GR only. This is in agreement with previous studies that 
have suggested a differential effect of MR and GR on cell death 
in rodents (Behl et al., 1997; Almeida et al., 2000). Moreover, it 
has been shown that GR-mediated apoptosis is counteracted by 
MR agonist aldosterone in hippocampal neurons (Crochemore 
et  al., 2005). In our study, chronic CORT treatment downregu-
lated GR expression levels in cortical neurons. Interestingly, 
pharmacological inhibition of GR deactivates the CamKII-BDNF-
CREB pathway that mediates long-term memory formation in 
hippocampal adult rats (Chen et  al., 2012). Of note, we dem-
onstrated that chronic CORT treatment decreases BDNF corti-
cal expression levels. This is in agreement with several studies 
showing decreased BDNF levels subsequent to chronic CORT 
treatment both in the rat frontal cortex (Dwivedi et  al., 2006) 
and hippocampus (Schaaf et al., 1998, 2000; Dwivedi et al., 2006).
In our study, CORT-induced reduction in both GR and BDNF 
expression levels was attenuated by DHA. This effect may rep-
resent a mechanism by which DHA reverses CORT-induced cel-
lular toxicity. Indeed, DHA has been shown to increase BDNF 
levels both in vitro (Rao et  al., 2007) and in vivo (Lipsky and 
Marini, 2007; Rao et al., 2007; Wu et al., 2008), suggesting poten-
tial neurotrophic and neuroprotective properties. However, at 
the timepoint of the analysis, the regulation of BDNF transcript 
was not correlated with the change in protein, which may be 
due to differences in the rate of transcription and translation 
and (or) in the half-life and stability of the mRNA and protein 
molecules (Vogel and Marcotte, 2012). With the noted limitations 
taken into consideration, it is worth noting that given BDNF’s 
involvement in neuronal survival and cell plasticity (Lipsky and 
Marini, 2007) and its expression levels regulated by GR (Chen 
et al., 2012), it is likely that both GR and BDNF are involved in the 
DHA-induced reversal of CORT-induced cellular changes in our 
cortical cultures.
Having established that pretreatment with DHA is able to 
prevent CORT-induced cellular changes in mixed cortical cul-
tures, future studies should focus on varying the time between 
each intervention and also investigate coadministration. 
Moreover, considering the correlation between Western diets, 
enriched in n-6 PUFAs, and the increased risk of development 
of stress-related pathologies, such as depression (Quirk et  al., 
2013), future studies should investigate the effect of n-6 PUFAs 
such as arachidonic acid in mixed cortical cultures. Arachidonic 
acid may induce comparable effects to CORT or increase its neg-
ative effects in mixed cortical cultures.
It is worth noting that all our results are based on data gen-
erated in cell culture systems. Such in vitro paradigms as well 
as animal models have limitations, and to date none faithfully 
recapitulate all of the clinical and pathological phenotypes of 
mental illnesses. Cellular models are instrumental in dissect-
ing a complex pathological process into simpler molecular 
events. Cell systems appear to be the correct choice for prelimi-
nary studies on the molecular action of new drugs or potential 
toxins and for understanding the role of single genetic factors. 
Indeed, this approach could lead to transformative new tools for 
the study of disease mechanisms and can be potentially used 
for high-throughput drug screening. Moreover, being rodent 
genome-based they represent a reliable preliminary investiga-
tion that requires confirmation in the same species of animal 
models for the direct investigation of pathophysiological char-
acteristics in far less time and a less labor-intensive manner.
In conclusion, we provided further evidence on the effects of 
CORT on neuronal apoptosis and astrocyte overgrowth as well 
as changes in BDNF expression levels and GR downregulation 
in mixed cortical cultures. Furthermore, we identified DHA as a 
novel compound able to reverse such changes. This study con-
tributes to our knowledge on the beneficial role of PUFAs that 
may be considered as future treatment strategies to counteract 
glucocorticoids-induced impairments in clinical settings.
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